Clinical trial

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

NCT06596018

Study summary

ClinicalTrials.gov

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

RADIATION · Unmapped registry intervention SBRT Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-12-25

PhasePHASE1 / PHASE2

Conditions

Breast Adenocarcinomaverified · MONDO: breast adenocarcinoma

Interventions

SBRTRADIATION

ChemotherapyDRUG

Sponsors & collaborators

Second Affiliated Hospital, Zhejiang University, School of Medicinelead sponsor

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06596018 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.